Search Results

You searched for: lupus nephritis
Results found: 174

Lupus Research Alliance Welcomes Voclosporin Trial Results

First Promising Phase II Data in Lupus Nephritis NEW YORK, NY — The Lupus Research Alliance congratulates Aurinia Pharmaceuticals on achieving the first positive Phase II study of a greatly needed potential treatment for lupus nephritis. Up to 60% of people with lupus develop lupus nephritis, a devastating complication that can cause kidney failure and […]

Re-engineering Immune Cells Opens Door to Promising Therapy for Lupus Kidney Inflammation

Research featured in Nature Communications highlights a novel approach that re-engineers a person’s own immune cells to suppress the overactive immune system that occurs in lupus nephritis, a serious and potentially life-threatening inflammation of the kidneys. With funding in part from the Lupus Research Alliance (LRA), associate professor Joshua Ooi, Ph.D. and his team at the […]

Lupus Research Alliance Awards Grants to Six Trailblazing Studies

2018 Awards Enable Promising Scientists to Bring Innovative Approaches to Lupus Research October 18, 2018 The Lupus Research Alliance announced six new Novel Research Grants to support paradigm-changing lupus research. To conquer the complexity of lupus, the Novel Research Grants support researchers who study lupus from many perspectives, testing new theories about what causes lupus and […]

ACR|ARHP News on Potential New Lupus Treatments

October 25, 2018 The Lupus Research Alliance was on the ground at the American College of Rheumatology 2018 meeting to bring you the latest news in lupus research and translation.  Several clinical trials showed benefits of potential new treatments for helping people with lupus. Following are summaries of the stand-out results: Ustekinumab (Stelara®) A Phase 2 […]

2017: A Year of Great Triumph for Lupus

Nov. 28, 2017. Thanks to you, the Lupus Research Alliance continues to make game-changing gains in advancing the basic understanding of lupus … while giving hope to millions of people that a potential cure is within reach. We Invested in Innovative Research The Lupus Research Alliance gave 19 scientists the means to bring their ideas […]

Discovering Lupus Heterogeneity

May 22, 2019 Lupus is heterogeneous, meaning that symptoms are many and vary widely from patient to patient — one person may develop a rash, while another may have high blood pressure, joint pain, and anemia. About two thirds of adults with lupus have above-normal levels of immune system molecules called type I interferons that […]

Promise of Additional Lupus Therapies Highlighted at ACR 2021 Annual Meeting

November 9, 2021 Results of clinical trials testing many existing and potential lupus treatments were highlighted at the American College of Rheumatology’s annual meeting ACR Convergence 2021, November 3-9. Bringing you the most relevant news for our lupus community, following are summaries of key research presented at the meeting: New Data on Approved Lupus Treatments […]

Lupus Signs and Symptoms

The most common symptoms of lupus are extreme fatigue, skin rashes, joint pain and unexplained fevers. Contact Lupus Research Alliance Today   Common Symptoms of Lupus Lupus Fatigue Approximately 50%–90% of people with lupus identify fatigue as one of their primary symptoms. A number of factors can contribute to fatigue in lupus, including the disease […]

Lupus Research Alliance-Funded Researchers Present Discoveries at ACR

October 29, 2018 More than 70 researchers who have received funding from the Lupus Research Alliance contributed to the scientific dialogue on lupus at the ACR|ARHP meeting this year. Following are highlights of specific discoveries the organization has supported: Tiring Out Rogue Cells Learning from cancer research, a team of scientists led by the inaugural […]